Arash Keshavarzi

Arash Keshavarzi, PhD, currently serves as an AI Investor at Mubadala Capital and as an Adjunct Lecturer leading a course on "AI in Drug Discovery" at Stanford University. With extensive experience in AI and biotechnology, Arash previously co-founded Lumos Bio, where a pioneering RNA targeting drug discovery platform was developed. Notably, Arash held the position of Chief Scientific Officer at Nucleus and has worked in AI roles at Labcorp and A2A Pharmaceuticals. Educational credentials include a PhD in Computational Biotechnology from the University of Central Florida and advanced studies at Stanford University and UCSF. Arash's research efforts and entrepreneurial ventures reflect a strong focus on leveraging artificial intelligence for impactful advancements in healthcare.